Outcomes of Same-Size Host and Donor Trephine in Deep Anterior Lamellar Keratoplasty for Keratoconus

Ting Huang,Chen Ouyang,Chao Hou,Qianni Wu,Yunwei Hu
DOI: https://doi.org/10.1016/j.ajo.2016.03.018
IF: 5.488
2016-01-01
American Journal of Ophthalmology
Abstract:PURPOSE: To evaluate the efficacy of the same-size host and donor trephine on reducing myopic refractive errors for patients with keratoconus when deep anterior lamellar keratoplasty (DALK) was used.DESIGN: Randomized controlled clinical trial.METHODS: One hundred eighteen eyes of 118 patients with keratoconus were enrolled. Using stratified blocked randomization, eligible eyes were allocated into the same-size trephine group or oversize trephine group. Postoperative uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), spherical equivalent (SE), topography data, and eye axial length were compared at each year for 5 years.RESULTS: The same-size trephine group had comparable UCVA to the oversize trephine group through 5 years after surgery. But the former had better BSCVA than the latter after 3 years of follow-up. At 5 years, mean BSCVA was 0.17 +/- 0.10 logMAR in the same-size trephine group vs 0.25 +/- 0.13 logMAR in the oversize trephine group (P = .03). The same-size trephine group had lower topographic power than the oversize trephine group after 3 years of follow-up. At 5 years, mean topographic power was 45.30 +/- 2.28 diopters (D) in the same-size trephine group vs 46.75 +/- 2.60 D in the oversize trephine group (P = .006). Eye axial lengths at 5 years were longer than those preoperatively as well as at 1 year follow-up after surgery in both groups.CONCLUSIONS: The same-size host and donor trephine could reduce late-stage myopic refractive errors for the patients with keratoconus after DALK. The mechanism may be late-stage axial length increase with time. (C) 2016 Elsevier Inc. All rights reserved.
What problem does this paper attempt to address?